Operation wipe out cervical cancer: How doctors plan to eliminate disease that is on the rise by 2033
Doctors are racing to cure cervical cancer in less than ten years, calling it that only cancer 'that we can say we can eliminate.' Experts have called for increased screenings and HPV vaccinations. (Source: the Mail online | Health)
Source: the Mail online | Health - January 25, 2024 Category: Consumer Health News Source Type: news
Komen calls for passing of state, federal legislation on breast care
Susan G. Komen issued a statement calling for the passing of state and federal legislation in 2024 to remove barriers preventing people from receiving necessary breast care, including imaging.
The organization said that these new laws, which have been or are planned to be introduced this year, are needed to eliminate healthcare inequities and provide people a fair chance in the fight against breast cancer.
Komen is advocating for the following legislation to be passed:
ul.editorialList li {margin-bottom:6px;}
SCREENS For Cancer Act: This would support state and local programs that provide no-cost breast and cervical...
Source: AuntMinnie.com Headlines - January 25, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Breast Imaging Source Type: news
The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - January 25, 2024 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Call To Action: Eradicating Cervical Cancer Through Innovation And Investment
An open letter by cervical cancer tech startups, Amplexd Therapeutics, Ananya Health, and Mission-Driven Tech, call for the innovation, research, and investment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 24, 2024 Category: Pharmaceuticals Authors: Brittany Barreto, Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare standard Source Type: news
Leadership roundtable event on women ’s health: addressing women’s cancers in the Eastern ...
18 January 2024 – Cairo, Egypt – The Egyptian Ministry of Health and Population, in collaboration with the WHO Regional Office for the Eastern Mediterranean successfully organized a landmark event as part of the Presidential Initiative on Women’s Health. Held on 18 January 2024 at the Hilton Heliopolis Hotel in Cairo, this roundtable event coincided with the 16th Annual Breast, Gynecological and Immunoncology International Cancer Conference forum and addressed the escalating challenges of breast and cervical cancer in the Eastern Mediterranean Region.
Organized under the auspices of His Excellency Professor Khaled A...
Source: WHO EMRO News - January 24, 2024 Category: Middle East Health Source Type: news
People urged to get HPV vaccine by health chiefs as figures show low vaccination rates
The HPV vaccine helps protect against a range of cancers, including cervical, head and neck, anal and genital cancers, which can affect both girls and boys. (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2024 Category: Consumer Health News Source Type: news
‘I’m a gynaecologist - here are four early signs of cervical cancer to look out for'
Cervical cancer is the 14th most common cancer among women in the UK, but like all cancers, knowing the symptoms is important. (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2024 Category: Consumer Health News Source Type: news
Toolkit for reducing cervical cancer risk
Cervical cancer is the fourth most common cancer in women globally, particularly in low- and middle-income countries. In the U.S., cervical cancer is no longer a common cause of cancer death because of the use of a screening test called a Pap smear, which detects changes in cervical cells. While the overall rate of cervical cancer in the U.S. is declining, the number of people diagnosed with late-stage cervical cancer is increasing, and rates among Black women are disproportionately high. Research also indicates… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 23, 2024 Category: Databases & Libraries Source Type: news
MRI radiomics help predict cervical cancer treatment outcomes
"Handcrafted" radiomics and deep-learning radiomics based on pretreatment MRI data help predict locally advanced cervical cancer (LACC) concurrent chemoradiotherapy treatment outcomes, according to research published January 12 in Scientific Reports.
The study results show promise for tailoring care for patients with this particular cancer, wrote a team led by Sungmoon Jeong, PhD, of Kyungpook National University, Daegu, South Korea.
"Our findings may contribute to the development of personalized treatment strategies for locally advanced cervical cancer patients," the group noted.
Cervical cancer is the fourth most comm...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Advanced Visualization Genitourinary Radiology Source Type: news
ACS: Cancer mortality declines, but incidence rates rise
Overall cancer mortality continues to decline, but incidence rates are up, according to a January 17 report by the American Cancer Society (ACS).
The report shows that there have been more than four million fewer deaths from cancer in the U.S. since 1991. However, it also showed increased incidence for six of the top 10 cancers as the projected number of new diagnoses is over two million for the first time.
“I think we’re all grappling with what the environmental factor that is changing the cancer incidence and mortality among the young," said ACS chief scientific officer William Dahut, MD, at a press conference.
AC...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties CT Breast Imaging Source Type: news
FDA Expands Pembrolizumab Approval in Cervical Cancer
(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) with chemoradiotherapy (CRT) for patients with stage III-IVA cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) 2014 criteria.
Pembrolizumab is the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 16, 2024 Category: American Health Source Type: news
FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer
The new approval marks the 40th oncology indication for pembrolizumab across 19 cancer types, including two previous metastatic cervical cancer approvals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 16, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Govt says yet to take decision on roll-out of HPV vaccination against cervical cancer
The Union Health Ministry in India clarified that it has not yet made a decision regarding the rollout of the Human Papillomavirus (HPV) vaccination against cervical cancer in the country. Dismissing media reports speculating about a vaccination campaign in the second quarter of 2024 for girls aged 9-14, the ministry stated that such reports are untrue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2024 Category: Pharmaceuticals Source Type: news
FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer
On January 12, 2024, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with chemoradiotherapy (CRT) for patients with FIGO 2014 Stage III-IVA cervical cancer. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Approval marks third FDA-approved indication for Keytruda in cervical cancer and 39th indication for Keytruda in the US
RAHWAY,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 12, 2024 Category: Drugs & Pharmacology Source Type: news
